# Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

> **NCT03634501** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 200 (estimated)

## Conditions studied

- Lung Cancer
- Breast Cancer
- Colon Cancer
- Pancreatic Cancer
- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** Activated NK

## Key facts

- **NCT ID:** NCT03634501
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-26
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634501, "Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03634501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*